Related content

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin

By Glueck Charles J.   Moreira Andrew   Goldenberg Naila   Sieve Luann   Wang Ping  

Human Reproduction, Vol. 18, Iss. 8, 2003-08 ,pp. : 1618-1625

Oxford University Press

Access to resources Recommend Favorite

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study

By Sahin I   Serter R   Karakurt F   Demirbas B   Culha C   Taskapan C   Kosar F   Aral Y  

Gynecological Endocrinology, Vol. 19, Iss. 3, 2004-09 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome

By Chen Mei-Jou   Yang Wei-Shiung   Chen Hsin-Fu   Kuo Jahn-Jahn   Ho Hong-Nerng   Yang Yu-Shih   Chen Shee-Uan  

Human Reproduction, Vol. 25, Iss. 3, 2010-03 ,pp. : 779-785

Oxford University Press

Access to resources Recommend Favorite

Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance

By Nawrocka Jolanta   Starczewski Andrzej  

Gynecological Endocrinology, Vol. 23, Iss. 4, 2007-04 ,pp. : 231-237

Informa Healthcare

Access to resources Recommend Favorite

Morning plasma cortisol is low among obese women with polycystic ovary syndrome

By Shabir Iram   Ganie Mohd Ashraf   Praveen Edavan P.   Khurana Madan L.   John Jomimol   Gupta Nandita   Kumar Guresh   Ammini Ariachery C.  

Gynecological Endocrinology, Vol. 29, Iss. 12, 2013-12 ,pp. : 1045-1047

Informa Healthcare

Access to resources Recommend Favorite